Crescent Biopharma, Inc

The annual 10-K, the quarterly 10-Q and the 8-K filed between them when something material happens.

1. Jul 30424B3Prospectus for an offering
2. Jul 3010-QQuarterly report
3. Jul 308-KResults of operations2.029.01
4. Jul 158-KOther events8.019.01
5. Jul 15424B5Prospectus for an offering
6. Jul 148-KResults of operations2.02
7. Jul 14424B5Prospectus for an offering
8. Jul 1S-3Shelf registration
9. Jun 22424B3Prospectus for an offering
10. Jun 38-KShareholder vote5.07
11. Apr 29424B3Prospectus for an offering
12. Apr 298-KResults of operations2.029.01
13. Apr 2910-QQuarterly report
14. Mar 17424B3Prospectus for an offering
15. Feb 26424B3Prospectus for an offering
16. Feb 268-KResults of operations2.029.01
17. Feb 2610-KAnnual report
18. Jan 15424B3Prospectus for an offering
19. Jan 7S-1Registration of new shares
20. Dec 4, 20258-KMaterial agreement and unregistered sale of shares1.013.027.018.019.01
21. Nov 6, 202510-QQuarterly report
22. Nov 6, 20258-KResults of operations2.029.01
23. Jul 31, 20258-KResults of operations and officer or director change2.025.029.01
24. Jul 31, 202510-QQuarterly report
25. Jun 18, 20258-KMaterial agreement and acquisition or sale of assets completed1.012.012.023.034.015.015.025.035.055.067.019.01
26. Jun 6, 20258-KRegulation FD disclosure and other events5.077.018.019.01
27. May 30, 20258-KOther events8.01
28. May 14, 202510-QQuarterly report
29. May 14, 2025424B3Prospectus for an offering
30. Apr 29, 20258-KMaterial agreement1.019.01
31. Feb 25, 20258-KOfficer or director change and end of a material agreement1.025.02
32. Feb 14, 20258-KMaterial agreement1.019.01
33. Feb 13, 202510-KAnnual report
34. Jan 31, 20258-KOfficer or director change5.02
35. Jan 13, 20258-KRegulation FD disclosure7.019.01
36. Dec 26, 20248-KListing notice or transfer3.01
37. Nov 13, 202410-QQuarterly report
38. Nov 7, 20248-KRegulation FD disclosure7.019.01
39. Oct 29, 20248-KMaterial agreement and unregistered sale of shares1.013.025.015.027.018.019.01